|
FCF1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6242562850266E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
6.89200030379311E-10 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.11022302462516E-16 |
| Stage1-vs-Stage2 |
7.050400E-01 |
| Stage1-vs-Stage3 |
2.530400E-01 |
| Stage1-vs-Stage4 |
3.755400E-03 |
| Stage2-vs-Stage3 |
2.693200E-01 |
| Stage2-vs-Stage4 |
2.172000E-02 |
| Stage3-vs-Stage4 |
1.237770E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.69042000000008E-05 |
| Normal-vs-Asian |
1.10370046435548E-10 |
| Caucasian-vs-AfricanAmerican |
1.066620E-01 |
| Caucasian-vs-Asian |
5.128600E-01 |
| AfricanAmerican-vs-Asian |
3.558000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
8.989900E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
8.3352000000092E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.306600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.222600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.695600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.866200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.582800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.635200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.221600E-02 |
| Classical-VS-Follicular |
2.922200E-01 |
| Classical-VS-Other |
1.338990E-01 |
| Classical-VS-Normal |
2.08155714886971E-12 |
| Tall-VS-Follicular |
1.625840E-01 |
| Tall-VS-Other |
7.348600E-01 |
| Tall-VS-Normal |
9.32587340685131E-14 |
| Follicular-VS-Other |
3.826400E-01 |
| Follicular-VS-Normal |
1.8508528043526E-12 |
| Other-VS-Normal |
5.50510000000282E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11022302462516E-16 |
| Normal-vs-N1 |
6.32827124036339E-15 |
| N0-vs-N1 |
3.717800E-02 |
|
|
